(24/7 MARKET NEWS) – Oncolytics Biotech Inc. (NASDAQ: ONCY) reported interim results from the phase 1/2 GOBLET study's first-line advanced/metastatic...

Biometrics

Rubius remains robust

by Ben

September 9, 2022

(24/7 MARKET NEWS) – Rubius Therapeutics Inc. (NASDAQ: RUBY) remains active in this morning’s premarket. Although its trading 2 cents...

Biometrics

(NASDAQ:IDAI) surging up over 260% premarket on 26th of April news

by 24/7 MarketNews Admin

April 28, 2022

Atlanta, GA , April 28, 2022 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI, Euronext Growth: AIID ID), the Privacy-First Identity...

MDxHealth Moving on UnitedHealthcare Commercial Coverage for the Genomic Prostate Score (GPS) Test News

Intelligent Bio Solutions Reports Boughey Distribution to Implement Fingerprint Drug Testing

SeqLL Enters 2 Year CRADA with the FBI

Genetic Technologies pulls back after Announcing $5M Registered Direct Offering

Biometrics

Oncolytics Biotech Reports Interim Results from Phase 1/2 GOBLET Study

Rubius remains robust

(NASDAQ:IDAI) surging up over 260% premarket on 26th of April news

Add New Playlist